VistaGen Therapeutics Inc investor relations material

VistaGen Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). Our lead product candidate PH94B is a rapid-onset neuroactive nasal spray targeted at the treatment of anxiety.